Dr. Ana Belén Pérez Oliva, disseminates the Project “mRNA nanoparticles for the development of new CAR-T therapies”, awarded by the Seneca Foundation, 
on the regional radio network COPE on April 12.
The Project aims to develop alternatives to the viruses currently used in the clinic for the development of CART therapies.
The new approach would reduce the current cost of such therapies and the side effects observed in the clinic.